News

The deal represents the establishment of RainTree Oncology’s national distribution network and enables the company to provide oral drug services to community oncology practices. RainTree Oncology CEO and

MBJ is involved in the manufacture, including contract manufacturing, and sale of pharmaceuticals (API, intermediates) made using proprietary production technology. The technology created by combining biotechnology with fermentation

MidaSol non-injectable Insulin addresses the unmet need of diabetic patients who are dependent on insulin injections by providing a more convenient, non invasive, treatment option. The companies are

Both the companies intend to lay emphasis on discovering small molecule drugs against oncology-relevant protein-protein interactions. As per the deal, Forma will receive a total of $65m in

The study was conducted under a contract sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Tetragenetics scientists produced

Provide Gold Liquid Protein, a berry flavored protein shot, is low calorie and sugar free, with only 60 calories per 1 ounce serving. Each Provide Gold Liquid Protein

EGP-437 is formulated for delivery using the EyeGate II drug delivery system, a non-invasive iontophoretic drug delivery technology. The Phase III randomized double-masked positive-controlled non-inferiority trial is expected

TRUE ATHLETE is NSF certified for Sport, minimizing the risk of unwanted contaminants, the company said. The new product line is formulated with premium ingredients to support one’s

The Phase I trial is a prospective open-label study, designed to demonstrate the safety, tolerability and pharmacokinetics of BAX 855 in previously-treated patients aged 12 years or older